Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

التفاصيل البيبلوغرافية
العنوان:	Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
المؤلفون:	Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg, Antoine N. Saliba, Anand Patel, Jan P. Bewersdorf, Adam S. DuVall, Danielle Bradshaw, Yasmin Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M. Zeidan, Vamsi Kota, Mark R. Litzow
المصدر:	Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
بيانات النشر:	Nature Publishing Group, 2024.
سنة النشر:	2024
المجموعة:	LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2044-5385
العلاقة:	https://doaj.org/toc/2044-5385Test
DOI:	10.1038/s41408-024-01000-2
الوصول الحر:	https://doaj.org/article/768054ee7a0b494192b71e0f348ee872Test
رقم الانضمام:	edsdoj.768054ee7a0b494192b71e0f348ee872
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	20445385
DOI:	10.1038/s41408-024-01000-2